India Pharma Outlook Team | Thursday, 27 November 2025
Samsung, a leading consumer electronics brand in India, has unveiled its ultra-premium, next-generation R20 ultrasound system for general imaging.
The R20 represents a significant advancement in imaging technology, integrating cutting-edge artificial intelligence, enhanced image resolution, and a user-friendly design that prioritizes clinician comfort and productivity.Powered by Samsung’s advanced Crystal Architecture, the R20 delivers outstanding image consistency, clarity, and depth across a wide range of general imaging applications. Its advanced imaging engine, robust GPU, and ultra-high-definition OLED display offer clinicians exceptional visualization and diagnostic confidence with every scan.
Also Read: Zydus & RK Pharma Sign US Oncology 505(b)(2) Licensing PacThe R20 features an extensive suite of AI-driven clinical and workflow enhancement tools that simplify complex procedures and automate routine tasks.Key technologies include Live LiverAssist, which detects suspicious focal lesions during real-time ultrasound examinations, and Live BreastAssist, which provides real-time identification of breast lesions along with BIRADS classification and reporting.The system also includes automatic measurement tools, offering AI-driven identification and quantification of internal structures with structured reporting for optimal consistency and efficiency. Additionally, it features Deep USFF—AI-driven deep ultrasound fat fraction quantification—demonstrated to have a strong correlation with the benchmark MRI PDFF.With its advanced imaging architecture, the R20 delivers exceptional performance across a variety of clinical applications, including abdomen, thyroid, musculoskeletal, vascular, breast, obstetrics, gynecology, and urology imaging. Enhanced Doppler sensitivity and color flow imaging enable healthcare professionals to visualize subtle vascular structures and conditions with greater accuracy and confidence. This versatility ensures that clinicians can obtain reliable, high-quality diagnostic results across diverse patient populations.
